AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TENOFOVIR ALAFENAMIDE FUMARATE
7 registrations across 3 African markets— 7 active
Markets with TENOFOVIR ALAFENAMIDE FUMARATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| HepBest Film-Coated Tablet | 🇰🇪Kenya | Mylan Laboratories Limited | active | Feb 2031 |
| Vemlidy 25 mg Tablets** Tablet | 🇳🇬Nigeria | Phillips Pharmaceuticals (Nigeria) Limited | active | Sept 2029 |
| TAFIGADO TABLET; ORAL | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED | active | Jan 2029 |
| TENOFOVIR ALAFENAMIDE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | LAURUS LABS LIMITED | active | Oct 2028 |
| TENOFOVIR ALAFENAMIDE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Jul 2028 |
| Hepbest 25 mg Tablet | 🇳🇬Nigeria | Healthline Limited | active | Sept 2026 |
| Getinomide Tablets 25 mg Tablet | 🇳🇬Nigeria | Getz Pharma Nigeria Limited | active | Nov 2025 |
TENOFOVIR ALAFENAMIDE FUMARATE in Africa — Regulatory Overview
TENOFOVIR ALAFENAMIDE FUMARATE is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Zimbabwe, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.